Frequent E-cadherin gene inactivation by loss of heterozygosity in pleomorphic lobular carcinoma of the breast.
Palacios, José; Sarrió, David; García-Macias, María C; Bryant, Bonita; Sobel, Mark E; Merino, María J.
; 16(7): 674-8, 2003 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-12861063
Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer.
Estrogen and progesterone receptor expression levels do not differ between lobular and ductal carcinoma in patients with hormone receptor-positive tumors.
Histopathologcial and clonal study of combined lobular and ductal carcinoma of the breast.
Comparative proteomic analysis of ductal and lobular invasive breast carcinoma.
Breast cancer: Role of IGF-1 and IGFBP-3 expression in prognostication.
Rho-GTPase activating-protein 18: a biomarker associated with good prognosis in invasive breast cancer.
Clinical outcome in pleomorphic lobular carcinoma: a case-control study with comparison to classic invasive lobular carcinoma.
Relapsed classic E-cadherin (CDH1)-mutated invasive lobular breast cancer shows a high frequency of HER2 (ERBB2) gene mutations.
Clinical role of HER2 gene amplification and chromosome 17: a study on 154 IHC-equivocal cases of invasive breast carcinoma patients.
An Analysis of Oncotype DX Recurrence Scores and Clinicopathologic Characteristics in Invasive Lobular Breast Cancer.